A ten year experience with hepatic resection.
The results of our experience have demonstrated that patients who undergo hepatic resection for primary or metastatic carcinomas have survival rates considerably higher than those reported in the literature for patients who do not undergo resection. Morbidity rates as well as survival rates among the patients we studied lie within the reported values of the major institutions. It is certainly clear that, within the past five years, metastatic disease to the liver from a primary carcinoma of the colon and rectum has become a treatable disease. We, therefore, advocate the aggressive approach to carcinoma of the liver and look forward to further advancement in the treatment of this disease.